Tanguler Tolga
SEC insider (Form 3/4/5 filer). CIK 0001849458. Director at Lexeo Therapeutics, Inc. (LXEO) and 1 other issuer. 97 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in NEW YORK, NY.
Companies Tanguler Tolga has filed insider reports for
- Lexeo Therapeutics, Inc. (LXEO): Director
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Officer, EVP, Chief Commercial Officer
Tanguler Tolga
CIK: 0001849458
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (97 total)
- Jun 25, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirectStock Option (right to buy)
35K shares- - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect272 shares at avg. $324.88$88K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect215 shares at avg. $320.81$69K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect350 shares at avg. $323.01$113K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect767 shares at avg. $323.84$248K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect208 shares at avg. $325.67$68K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect106 shares at avg. $319.03$34K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect102 shares at avg. $320.01$33K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect289 shares at avg. $321.82$93K - Mar 2, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect392 shares at avg. $326.81$128K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  LXEO Lexeo Therapeutics, Inc. | Award Stock Option (right to buy) | 35,000 | - | - | Direct |
| Mar 4, 2026 |  ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 272 | $324.88 | $88,367 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 215 | $320.81 | $68,974 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 350 | $323.01 | $113,054 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 767 | $323.84 | $248,385 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 208 | $325.67 | $67,739 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 106 | $319.03 | $33,817 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 102 | $320.01 | $32,641 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 289 | $321.82 | $93,006 | Direct |
| Mar 2, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 392 | $326.81 | $128,110 | Direct |
1-10 of 97 transactions